Form 4: Jaguar Health Director John Micek Granted Stock Options

Director John Micek of Jaguar Health, Inc. was granted stock options for 26,500 shares of common stock on October 8, 2024.

Summary

• John Micek, a director of Jaguar Health, Inc., was granted stock options to purchase 26,500 shares of the company's common stock.
• The transaction occurred on October 8, 2024.
• The exercise price of the options is $1.29 per share.
• The options were granted under the company's 2014 Stock Incentive Plan.
• The options vest 100% on the first anniversary of the grant date, contingent upon Micek's continued service on the board of directors of Jaguar Health and its subsidiary, Napo Therapeutics, S.p.A.
• The options expire on October 8, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a standard practice and generally viewed as a positive incentive for directors, aligning their interests with shareholders.

Positives

• The granting of stock options to a director aligns their interests with those of the shareholders, incentivizing them to work towards the company's success.
• The vesting schedule encourages continued service and commitment from the director.

Industry Context

Stock options are a common form of executive compensation used to align the interests of management and shareholders in publicly traded companies. This grant is a standard practice to incentivize directors.

Comparison to Industry Standards

• Stock option grants are a typical component of director compensation packages in publicly traded companies, particularly in the biotechnology and pharmaceutical sectors.
• The vesting schedule of one year is fairly standard, aligning with common industry practices for incentivizing long-term commitment.
• Comparable companies like Catalyst Pharmaceuticals or Agenus Inc. also utilize stock options as part of their director compensation packages.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive incentive for the director.
• The director is incentivized to increase shareholder value through their service on the board.

Key Dates

Keywords

stock options, Jaguar Health, director, John Micek, Napo Therapeutics, equity compensation, Form 4